3/27
04:45 pm
bbnx
Beta Bionics Announces Board Appointment of Gerard Michel
Medium
Report
Beta Bionics Announces Board Appointment of Gerard Michel
3/25
04:02 pm
bbnx
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
High
Report
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
2/27
07:00 am
bbnx
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
Low
Report
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
2/25
06:07 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
Beta Bionics, Inc. (NASDAQ: BBNX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
2/24
01:44 pm
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Bank of America Co.. They set a "buy" rating on the stock.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Bank of America Co.. They set a "buy" rating on the stock.
2/24
09:19 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $30.00 price target on the stock.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $30.00 price target on the stock.
2/24
07:07 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $28.00 price target on the stock.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $28.00 price target on the stock.
2/24
07:07 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $26.00 price target on the stock.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $26.00 price target on the stock.
2/24
07:07 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $25.00 price target on the stock.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $25.00 price target on the stock.
2/21
07:30 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) was upgraded by analysts at Baird R W to a "hold" rating.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) was upgraded by analysts at Baird R W to a "hold" rating.
2/20
08:46 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "neutral" rating and a $20.00 price target on the stock.
Medium
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "neutral" rating and a $20.00 price target on the stock.
2/20
07:13 am
bbnx
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $20.00 price target on the stock.
Low
Report
Beta Bionics, Inc. (NASDAQ: BBNX) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $20.00 price target on the stock.
1/31
05:56 pm
bbnx
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Medium
Report
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
1/29
10:34 pm
bbnx
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
Medium
Report
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering